Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:NUVA

NuVasive (NUVA) Stock Price, News & Analysis

NuVasive logo

About NuVasive Stock (NASDAQ:NUVA)

Advanced Chart

Key Stats

Today's Range
$39.75
$39.75
50-Day Range
$38.12
$40.66
52-Week Range
$35.17
$49.53
Volume
N/A
Average Volume
1.16 million shs
Market Capitalization
$2.08 billion
P/E Ratio
79.50
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone; and fixation system that facilitates the preservation and restoration of patient alignment. The company also offers cervical total disc replacement technology for cervical spinal fusion surgery; neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology, and its intraoperative neuromonitoring services and support; and Pulse platform, a software ecosystem that integrates multiple hardware technologies into a single, condensed footprint in the operating room. In addition, it provides expandable growing rod implant systems for the treatment of early-onset scoliosis; various biologics that are used to aid in the spinal fusion or bone healing process; Precice, an intramedullary device that utilizes the MAGEC technology to non-invasively lengthen the femur and tibia; and onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California. As of September 1, 2023, NuVasive, Inc. operates as a subsidiary of Globus Medical, Inc.

Receive NUVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NuVasive and its competitors with MarketBeat's FREE daily newsletter.

NUVA Stock News Headlines

Globus Medical: Some Caution After Its Deal For Nevro
Trump’s Secret Social Security Plan?
In less than a decade, Social Security could be out of money. But a surprising plan from Trump’s inner circle may not just save the system — it could unlock a major opportunity for savvy investors. Financial insider Jim Rickards calls it “Social Prosperity,” and says those who act now could see the biggest gains.
Globus acquisition of Nevro complicates story, says Stifel
Globus Medical raises FY24 revenue view to $2.52B from $2.49B-$2.5B
Globus Medical Stock: Re-Rated After A Solid Year
See More Headlines

NUVA Stock Analysis - Frequently Asked Questions

NuVasive, Inc. (NASDAQ:NUVA) announced its quarterly earnings results on Wednesday, August, 2nd. The medical device company reported $0.56 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.56. The firm's revenue was up 2.4% on a year-over-year basis.
Read the conference call transcript
.

The following companies are subsidiaries of NuVasive: Simplify Medical, SafePassage, Vertera Spine, Biotronic NeuroNetwork, Ellipse Technologies, NuVasive Clinical Services Monitoring Inc., NuVasive Japan KK, NuVasive Specialized Orthopedics Inc., and NuVasive Technology International Limited.

Based on aggregate information from My MarketBeat watchlists, some other companies that NuVasive investors own include Meta Platforms (META), Tesla (TSLA), NVIDIA (NVDA), First Solar (FSLR), Netflix (NFLX), Advanced Micro Devices (AMD) and Home Depot (HD).

Company Calendar

Last Earnings
8/02/2023
Today
4/26/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Devices
Sub-Industry
Health Care Equipment
Current Symbol
NASDAQ:NUVA
Employees
3,000
Year Founded
1997

Profitability

Trailing P/E Ratio
79.50
Forward P/E Ratio
17.91
P/E Growth
N/A
Net Income
$40.41 million
Pretax Margin
3.41%

Debt

Sales & Book Value

Annual Sales
$1.23 billion
Cash Flow
$4.96 per share
Price / Cash Flow
8.01
Book Value
$17.02 per share
Price / Book
2.34

Miscellaneous

Free Float
52,171,000
Market Cap
$2.08 billion
Optionable
Optionable
Beta
1.07

Social Links

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:NUVA) was last updated on 4/26/2025 by MarketBeat.com Staff
From Our Partners